scPharmaceuticals Inc Sustainability Reports
scPharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing products that enable subcutaneous administration of therapies traditionally limited to intravenous delivery. Its lead commercial product is FUROSCIX, an on-body infuser system designed to treat fluid overload in adults with chronic heart failure or chronic kidney disease.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300F55SN4ZR2OA180
FIGI: BBG00J24RT22
4 reports from 2018 to 2024